Oxford Cannabinoid Technologies "proceeding forward as planned" after review meeting

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) CEO Clarissa Sowemimo-Coker speaks to Proactive after announcing that a Research Ethics Committee (REC) review meeting for its lead programme OCT461201 has now taken place. Sowemimo-Coker says the company is "proceeding forward as planned" and has "hit the ground running" in 2023.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.67
+0.00 (0.00%)
AAPL  276.97
+0.00 (0.00%)
AMD  206.13
+0.00 (0.00%)
BAC  52.48
+0.00 (0.00%)
GOOG  323.64
+0.00 (0.00%)
META  636.22
+0.00 (0.00%)
MSFT  476.99
+0.00 (0.00%)
NVDA  177.82
+0.00 (0.00%)
ORCL  197.03
+0.00 (0.00%)
TSLA  419.40
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.